Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
about
Development and novel therapeutics in hepatocellular carcinoma: a reviewControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaPrevention of infection-related cancers in the WHO Western Pacific RegionHepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measuresManagement of chronic hepatitis B in pregnancyPrevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in NepalStrategy vaccination against Hepatitis B in ChinaNew loci associated with chronic hepatitis B virus infection in Han ChinesePrevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of NepalCost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in ChinaEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, ChinaAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China.Comparison of risk adjustment methods in patients with liver disease using electronic medical record dataObstetrical disease spectrum in China: an epidemiological study of 111,767 cases in 2011Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study.The Clinical Efficacy and Adverse Effects of Interferon Combined with Matrine in Chronic hepatitis B: A Systematic Review and Meta-Analysis.Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmissionProtective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failureClinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.A population-based study examining hepatitis B virus infection and immunization rates in Northwest ChinaMolecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.Real-time PCR assays for hepatitis B virus DNA quantification may require two different targets.A pilot study on screening blood donors with individual-donation nucleic acid testing in China.Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental modelDetection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe.Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controlsPatient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.A description of the hepatitis B virus genomic background in a high-prevalence area in ChinaEvaluation of the impact of hepatitis B vaccination in adults in Jiangsu province, ChinaWhole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, ChinaEvaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies.Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysisA novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.Gateway to Care campaign: a public health initiative to reduce the burden of hepatitis B in Haimen City, ChinaAlpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China
P2860
Q26752854-795E91B6-9ABD-41F0-92BA-D9CFB3DD243DQ26772324-315A44A7-B136-4CA1-911C-5351CD7C5ACAQ26777318-CCDF002A-968A-47EE-8592-9CB0037125ECQ26829313-2E6A185C-DE1E-4E3A-A945-C81CD83D6D6CQ27026593-A89C95F2-3DE6-4335-AEEC-6A96C9A9B0B7Q27303069-2D530DEF-9D61-4F35-A642-29E48E51540EQ28081068-A6029053-5EAE-4F1E-A39C-968D83134269Q28300932-515D2FE1-4D5D-4A66-B50C-B515002685FAQ28547151-92F17482-45BC-41E0-8D07-E12A15BA102DQ28550643-F9633844-12CA-419D-90FA-5BD155E5E8EDQ30244568-3EA233E9-24EF-4D7A-9F25-9351C8EFCCB3Q30362020-1515F7A3-A848-4FC4-9D41-103E67B2CF62Q30377094-E414165D-49BA-4268-AF61-28CF59B48517Q30391932-F213FF72-BC9E-4AB8-9340-6DF339B783E3Q30489050-C114F0B3-86A1-4982-85DB-0DDA8CFB52FEQ31153329-0A7648D5-88DC-43E5-A965-CFC7C9A6D08EQ33422599-92955A78-C503-47C1-990B-EB58DEFA8897Q33425621-871CBD8E-C468-40E7-B1E1-90E47085B6C6Q33440730-8CE31356-C7B2-4435-8C1F-3C54BA4C3A21Q33455459-06A57F21-5946-44A1-B93F-460B72007DB6Q33560668-38B4F138-98EA-4CCE-83C6-7C4D24F82CE6Q33590502-1A18C09D-901E-44F9-86E5-EC435D2108CEQ33606219-AC0B8D63-8349-49FD-A342-F0AE171321EFQ33618408-853C3F40-AE74-4133-8B1C-ED00274E795AQ33623694-37DB177A-D79E-477A-AA12-6F99377BC4F2Q33667860-D480D6E4-F72F-4FF4-B6FA-0027C09DD18DQ33690837-97819561-F264-4508-BBEE-267DA5E449CEQ33767254-4BE99A4D-FE6F-43D7-A207-E4F11E3EBF86Q33769738-2F969218-4A82-4F94-AB4D-4D10543FA750Q33792387-827CCA33-BAFA-4320-9A48-EE2033A41D8BQ33800651-9DD75724-F239-4065-9D50-AD6BB793E267Q33820478-C0F4C1BE-F2E7-494D-93FF-810B5274378EQ33825839-CFF5E9C9-2F51-4D1A-8F0B-A70F9B361DB8Q33842386-87574224-6333-4BDA-BD65-9CE89920F4C5Q33847453-76A7BC21-F9D8-4AF0-BA53-4A9A8636B098Q33884821-33F5E8FC-53BD-47C7-9D89-B1D8257B32CEQ33945175-ABBC81F1-9E9A-4469-8477-5D547515C167Q34012123-63D55B1D-6590-4B83-9E47-846A32D2FC07Q34071329-698B9F4D-4DC3-4051-A609-09F5F4B9B3B6Q34097882-09622AE2-B126-4776-A7E0-0C123BC75440
P2860
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@en
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@nl
type
label
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@en
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@nl
prefLabel
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@en
Epidemiological serosurvey of ...... ue to hepatitis B vaccination.
@nl
P2093
P1433
P1476
Epidemiological serosurvey of ...... due to hepatitis B vaccination
@en
P2093
Fuqiang Cui
Fuzhen Wang
Huaqing Wang
Huiming Luo
Jianhua Liu
Jingchen Ma
P304
P356
10.1016/J.VACCINE.2009.08.048
P407
P577
2009-09-01T00:00:00Z